Lexaria Bioscience Corp. (LEXX): 6 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jul 30, 2025 | Christopher Richard Director, Officer | 15,000 | $0.91 | $13.7K | no history |
| Jul 30, 2025 | Carle Vanessa Officer | 750 | $0.91 | $682 | no history |
| Jul 30, 2025 | Docherty John Martin Director, Officer | 5,376 | $0.93 | $5.0K | no history |
| Jul 30, 2025 | McKechnie William Edward Director | 5,000 | $0.91 | $4.5K | no history |
| Jul 30, 2025 | Bunka Christopher Director | 27,500 | $0.92 | $25.2K | no history |
| Dec 3, 2024 | Christopher Richard Officer | 50,000 | $2.36 | $118.2K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.